John Chaddock

Inventor

Add to Portfolio

Stats

Details

Work History

Patent OwnerApplications FiledYear
SYNTAXIN LIMITED
2
1
2
2
7
3
6
1
1
2002
2003
2005
2006
2007
2008
2009
2010
2012
ALLERGAN, INC.
4
3
3
6
9
4
1
1
1
2005
2007
2010
2011
2012
2013
2014
2016
2017
THE SPEYWOOD LABORATORY LIMITED
2
2
2008
2009
Microbiological Research Authority and The Speywood Laboratory Limited
1
2002
HEALTH PROTECTION AGENCY
2
2006
The Health Protection Agency Ipsen Limited
1
2002
IPSEN BIOINNOVATION LIMITED
1
6
6
1
2
6
12
7
2
1
1
2004
2005
2007
2009
2010
2011
2012
2013
2014
2016
2017
SYNTAXIN LIMITED, Salisbury
1
2009
THE SECRETARY OF STATE FOR HEALTH
2
1
2
2
6
2
2002
2003
2005
2008
2009
2010

Inventor Addresses

AddressDuration
Abingdon Oxfordshire, GBMay 29, 14 - May 29, 14
Abingdon, GBFeb 03, 11 - Feb 15, 22
Oxon, GBMar 19, 13 - Mar 19, 13
Salisbury, GBSep 04, 03 - Apr 14, 20
Salisbury, Wiltshire, GBJun 11, 09 - Jun 11, 09
Wiltshire, GBMay 25, 06 - Sep 30, 10

Technology Profile

Technology Matters
A61K: PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 41
A61P: THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 15
C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 14

See more…

Patents / Publication

Patents / Publication #Year of Publication / IssuedTitleCitations
112482192022Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and a targeting moiety that binds a galanin receptor and methods for treating, preventing or ameliorating pain using such fusion proteins0
107040382020Therapeutic fusion proteins3
106191462020Non-cytotoxic protein conjugates0
2019/0309,2772019FUSION PROTEINS AND METHODS FOR TREATING, PREVENTING OR AMELIORATING PAIN2
2019/0062,7212019THERAPEUTIC FUSION PROTEINS3

See more…


We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
> Upgrade to our Level for up to -1 portfolios!.